Skip to content
AnalystLens

UNITEDHEALTH GROUP INC 8-K/A Report, Executive Changes (Apr 17, 2024)

Reports
Leadership Changes
Filing Date
Filed April 17, 2024
Period End
March 28, 2024
Security
UNH
In the record · 2016–202610-K1110-Q328-K173

UNH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 173 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Feb ’22Feb ’22
  2. Leadership change8-K · Mar ’26Mar ’26

Summary

Summary of the 8-K/A filed April 17, 2024. Cited figures are marked; the original filing is the authoritative source.

This 8-K/A filing from UnitedHealth Group Inc. (UNH) provides an amendment related to the compensation arrangements for Mr. Rex, a key executive.

Specifically, it details the approval of his annual base salary, cash incentive award, and various stock-based awards by the Compensation and Human Resources Committee. These updates offer clarity on the remuneration structure for a senior member of the management team, which is a crucial aspect for investors to understand executive incentives and potential future share dilution. The approved compensation includes a base salary of $1,400,000,a with a target annual cash incentive award of 200% of his base salary.

Furthermore, Mr. Rex received significant stock awards, comprising stock options valued at $150,000,b restricted stock units (RSUs) valued at $150,000, and performance shares valued at $300,000. These elements are designed to align executive compensation with company performance and shareholder value, providing insights into how the company retains and motivates its top talent.

Key Highlights

  1. Amendment to a previous filing concerning executive compensation.
  2. Compensation for Mr. Rex, a key officer, has been updated.
  3. Annual base salary for Mr. Rex set at $1,400,000.
  4. Target annual cash incentive award opportunity is 200% of base salary.
  5. Stock awards granted to Mr. Rex include: stock options ($150,000 value), restricted stock units ($150,000 value), and performance shares ($300,000 value).
  6. The Compensation and Human Resources Committee approved these new compensation arrangements.

Frequently Asked Questions

  1. What is the primary purpose of this 8-K/A filing?

    The primary purpose of this filing is to amend a previous report by detailing the approved compensation package for Mr. Rex, a key executive at UnitedHealth Group Inc., including his base salary, cash incentive, and stock awards.

  2. What is the total value of the stock awards granted to Mr. Rex?

    The total value of the stock awards granted to Mr. Rex is $600,000, consisting of $150,000 in stock options, $150,000 in restricted stock units, and $300,000 in performance shares.

  3. How is Mr. Rex's annual cash incentive determined?

    Mr. Rex's annual cash incentive award opportunity has a target value of 200% of his base salary, which is $1,400,000. The actual payout would likely depend on company and individual performance metrics.

  4. Does this filing indicate any changes to Mr. Rex's role or departure?

    No, this filing specifically addresses Mr. Rex's compensation arrangements and states that 'Other aspects of Mr. Rex’s compensation were not affected,' implying no changes to his role or departure are being disclosed in this context.